Current challenges in diabetes management

Clinical Cornerstone

Volumn 7, Issue SUPPL. 3, 2005, Pages S6-

  Blonde, Lawrence ^a  

^a Oschner Clinic Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FENOFIBRATE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LIPID; METFORMIN; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; SULFONYLUREA; TROGLITAZONE;

ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE COURSE; DRUG USE; DYSLIPIDEMIA; EARLY INTERVENTION; GLYCEMIC CONTROL; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INDIVIDUALIZATION; INSULIN HYPOGLYCEMIA; INSULIN TREATMENT; LIFESTYLE; LIPID ANALYSIS; PATIENT COMPLIANCE; PATIENT EDUCATION; RISK REDUCTION; TREATMENT PLANNING; WEIGHT GAIN;

EID: 33644912381     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(05)80084-5     Document Type: Article

References (51)

1. Available at: http://www.diabetes.org American Diabetes Association All About Diabetes. Diabetes Statistics Accessed December 6, 2005 2005 National Diabetes Fact Sheet
2. McBean A.M. Li S. Gilbertson D.T. Collins A.J. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ ethnic groups: Whites, blacks, Hispanics, and Asians Diabetes Care 27 2004 2317-2324
3. Narayan K.M. Boyle J.P. Thompson T.J. et. al. Lifetime risk for diabetes mellitus in the United States Jama 290 2003 1884-1890
4. American Diabetes Association Economic costs of diabetes in the U.S. in 2002 Diabetes Care 26 2003 917-932
5. Flegal K.M. Carroll M.D. Ogden C.L. Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000 Jama 288 2002 1723-1727
6. Available at: National Diabetes Information Clearinghouse (NDIC) National diabetes statistics Accessed August 9, 2005 http://diabetes.niddk.nih.gov/dm/pubs/statistics/
7. Gilmer T. O'Connor P.J. Rush W.A. et. al. Predictors of health care costs in adults with diabetes Diabetes Care 28 2005 59-64
8. Gaede P. Vedel P. Larsen N. et. al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med. 348 2003 383-393
9. Stratton I.M. Adler A.I. Neil A.W. et. al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study Bmj 321 2000 405-412
10. Testa M.A. Simonson D.C. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. A randomized, controlled, double-blind trial Jama 280 1998 1490-1496
11. Gray A. Raikou M. McGuire A. et. al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside ran domizedcontrolled trial (UKPDS 41) Bmj 320 2000 1373-1378
12. Herman W.H. Hoerger T.J. Brandle M. et. al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance Ann Intern Med. 142 2005 323-332
13. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of inten sive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study Jama 290 2003 2159-2167
14. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus Jama 287 2002 2563-2569
15. Nathan D.M. Lachin J. Cleary P. et. al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus N Engl J Med. 348 2003 2294-2303
16. American Diabetes Association Standards of medical care in diabetes Diabetes Care 28 Suppl 1 2005 S4-S36
17. American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes SelfManagement-2002 Update Endocr Pract. 8 Suppl 1 2002 43-56
18. Available at: http://www.cadre-diabetes.org/em/pdf/newsletters/archive/ CADRE Council for the Advancement of Diabetes Research and Education CADRE's AIC Position Accessed August 9, 2005 Curr Diabetes Pract. 1 2002 1-8
19. Lyons T.J. Jenkins A.J. Zheng D. et. al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort Invest Ophthalmol Vis Sci. 45 2004 910-918
20. Jenkins A.J. Lyons T.J. Zheng D. et. al. Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy Kidney Int. 64 2003 817-828
21. American Diabetes Association Standards of medical care in diabetes Diabetes Care 28 Suppl 1 2005 S4-S36
22. Saydah S.H. Fradkin J. Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes Jama 291 2004 335-342
23. Available at: http://www.ndep.nih.gov/campaigns/besmart/ besmart_index.htm National Diabetes Education Program Awareness campaign: Be smart about your heart: Control the ABCs (AIC, blood pressure, and cholesterol) Accessed December 15, 2005
24. Koro C.E. Bowlin S.J. Bourgeois N. Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes Diabetes Care 27 2004 17-20
25. Available at: http://www.aace.com/newsroom/press/2005/ index.php?r=20050518 American Association of Clinical Endocrinologists State of diabetes in America: A new report reveals America's diabetes health is in jeopardy Accessed December 15, 2005
26. Brown J.B. Nichols G.A. Perry A. The burden of treatment failure in type 2 diabetes Diabetes Care 27 2004 1535-1540
27. [published correction appears in Diabetes Care. 2002;25:12681) Wright A. Burden A.C. Paisey R.B. et. al. Sulfonylurea inadequacy. Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57) Diabetes Care 25 2002 330-336
28. NHIS Summary Health Statistics for US Adults: National Health Intervention Survey 2003 http://www.cdc.gov/nchs/data/series/sr_10/ sr10225.pdf
29. Cefalu W.T. LeRoith D. Council for the Advancement of Diabetes Research and Education Overcoming the barriers for achieving standards of diabetes care: The formation of CADRE Diabetes Technol Thera. 5 2003 385-392
30. Cramer J.A. A systematic review of adherence with medications for diabetes Diabetes Care 27 2004 1218-1224
31. Implementation Conference for ACE Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position Statement July 8, 2005 Available at: http://www.diabetsnpo.im.wustl.edu/resources/documents/ ACEPositionStatementsDiabetes.pdf
32. The Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group Jama 287 2002 2563-2569
33. Buchanan T.A. Xiang A.H. Peters R.K. et. al. Preservation of pancreatic βcell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women Diabetes 51 2002 2796-2803
34. Viberti G. Kahn S.E. Greene D.A. et. al. A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, andmetformin in recently diagnosed type 2 diabetes Diabetes Care 25 2002 1737-1743
35. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med. 346 2002 393-403
36. Lindstrom J. Eriksson J.G. Valle T.T. et. al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: Results from a randomizedclinical trial J Am Soc Nephrol. 14 2003 S108-S113
37. Knowler W.C. Hamman R.F. Edelstein S.L. et. al. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program Diabetes 54 2005 1150-1156
38. Chiasson J.-L. Josse R.G. Gomis R. et. al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. The STOP-NIDDM Trial Jama 290 2003 486-494
39. Gerich J.E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia Arch Intern Med. 163 2003 1306-1316
40. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and ComplicationsTrial Diabetes 44 1995 968-983
41. Blonde L. Rosenstock J. Mooradian A.D. et. al. Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulpho nylurea therapy Diabetes Obes Metab. 4 2002 368-375
42. Fonseca V. Rosenstock J. Patwardhan R. Salzman A. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: A randomized controlled trial Jama 283 2000 1695-1702
43. Garber A. Donovan D.S. Jr Dandona P. et. al. Efficacy of glyburide/ metformin tablets compared with initial monotherapy in type 2 diabetes J Clin Endocrinol Metab. 88 2003 3598-3604
44. Riddle M.C. Rosenstock J. Gerich J. et. al. The Treat-toTarget Trial. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 2003 3080-3086
45. Raskin P. Allen E. Hollander P. et. al. Initiating insulin therapy in type 2 diabetes Diabetes Care 28 2005 260-265
46. American Association of Clinical Endocrinologists The road map for the prevention and treatment of type 2 diabetes Available at: http://www.aace.com/mectings/consensus/odimplementation/roadmap.pdf Accessed December 15, 2005
47. Karter A.J. Ackerson L.M. Darbinian J.A. et. al. Selfmonitoring of blood glucose levels and glycemic control: The Northern California Kaiser Permanente Diabetes Registry Am J Med. 111 2001 1-9
48. National Diabetes Education Program Awareness campaign: Control your diabetes for life Available at: http://www.ndep.nih.gov/campaigns/ ControlForLife/ControlForLife_index.htm Accessed December 15 2005
49. Available at: National Diabetes Education Program Awareness campaign: Small steps, big rewards: Prevent type 2 diabetes Accessed December 15, 2005 ttp://www.ndep.nih.gov/campaigns/SmallSteps/SmallSteps_index.htm
50. Available at: American Diabetes Association Weight Loss & Exercise. Weight Loss Matters Accessed December 15, 2005 and
51. American Diabetes Association Diabetes Prevention. Diabetes PHDPersonal Health Decisions. Available at: http://www.diabetes.org/diabetesphd/ default.jsp Accessed December 15, 2005